A phase II Clinical Study of CP-4055 as second line therapy in patients with advanced colorectal cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-006766-41

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the objective tumour response in patients with advanced colorectal cancer when treated with CP-4055 for infusion D1-5/4w.


Critère d'inclusion

  • A phase II clinical study of ELACYT as second line therapy in patients with advanced colorectal cancer

Liens